Drug profile · INN
xenon xe-129 hyperpolarized
XENOVIEW
xenon xe-129 hyperpolarized (XENOVIEW) is a mri contrast agent. Route of administration: inhalation. Current US regulatory status: approved.
Drug details — xenon xe-129 hyperpolarized
- US status
- approved
- Class
- —
- Route
- INHALATION
- Patents
- 0
- Programs
- 4
- Data quality
- 0.84
Quick answer
xenon xe-129 hyperpolarized (XENOVIEW) is a mri contrast agent. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Mechanism of action
MRI contrast agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is xenon xe-129 hyperpolarized?
xenon xe-129 hyperpolarized (XENOVIEW) is a mri contrast agent. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for xenon xe-129 hyperpolarized?
XENOVIEW is a marketed brand name for xenon xe-129 hyperpolarized. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of xenon xe-129 hyperpolarized?
xenon xe-129 hyperpolarized has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.